about
Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signalingSex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption.Correction: Sex-Dependent Psychoneuroendocrine Effects of THC and MDMA in an Animal Model of Adolescent Drug ConsumptionThe CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K+ channelsDevelopmental and ageing changes in aminopeptidase activities in selected tissues of the ratK(+) channel expression distinguishes subpopulations of parvalbumin- and somatostatin-containing neocortical interneuronsPharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods.Microglial activation underlies cerebellar deficits produced by repeated cannabis exposureDissociation of the pharmacological effects of THC by mTOR blockade.Advances in the field of cannabinoid--opioid cross-talk.Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation.Neurochemical basis of cannabis addiction.New insights into the molecular pathophysiology of fragile X syndrome and therapeutic perspectives from the animal model.Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by delta9-Tetrahydrocannabinol.Glutamatergic stimulation induces GluN2B translation by the nitric oxide-Heme-Regulated eIF2α kinase in cortical neurons.Distribution of Kv3.3 potassium channel subunits in distinct neuronal populations of mouse brain.Pharmacological and immunological characterization of solubilized 130-140- and 66-kD imidazoline receptors in the rat brain.Differential subcellular localization of the two alternatively spliced isoforms of the Kv3.1 potassium channel subunit in brain.Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims.Targeting the endocannabinoid system in the treatment of fragile X syndrome.A unique role for Kv3 voltage-gated potassium channels in starburst amacrine cell signaling in mouse retina.Impaired fast-spiking, suppressed cortical inhibition, and increased susceptibility to seizures in mice lacking Kv3.2 K+ channel proteins.Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype.Lack of effect of reserpine on immunoreactive imidazoline receptor proteins in rat brain.Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.Physiological Control of Nitric Oxide in Neuronal BACE1 Translation by Heme-Regulated eIF2α Kinase HRI Induces Synaptogenesis.The cannabis paradox: when age matters.CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal.Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts.H2 histamine receptor-phosphorylation of Kv3.2 modulates interneuronfast spikingPossible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse ModelΔ9-tetrahydrocannabinol modulates the proteasome system in the brainMolecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brainA bilateral study of aminopeptidase activity in the adrenal gland of young and aged ratsSerotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortexAuricular transcutaneous vagus nerve stimulation improves memory persistence in naïve mice and in an intellectual disability mouse model
P50
Q28253698-4C3AA32B-B059-435D-BA6E-FF2550D74DFBQ28534825-D0A4CCEE-063B-4CC7-A421-2EBD20A8B4B7Q28537741-3F127B9E-13F9-4EAD-9A17-7EC62917B2ABQ28568564-A7653B83-9A8F-437E-9176-922E3B7F7F06Q28578651-F3ED66A3-D395-458E-B5A8-4C536DD148F7Q28586133-9262A2E2-F826-4763-8D3C-003AA7439D99Q33693033-D78A060D-D108-49C9-A897-FF14E1CBCBD4Q34363232-D3777823-F18E-459D-84A0-9448D39AAEB3Q36850581-49C4005B-76F4-40DD-A885-911820B0D3D2Q37164808-E684E515-5EA4-4623-92C7-0F3A89E50779Q37258625-CE434131-798A-4FAA-8BBF-719DE8961AA9Q37844898-C41628E7-3D88-4991-B79F-804F93E3D2FEQ38212021-EAD422FE-AEA4-4083-A4C2-AB0A7F438858Q38620645-DA53B58F-2C33-4DC2-AEE0-28B56146F10AQ39457267-8A7B0053-25EC-4FA1-956F-7558DD75E276Q40143828-F9FD6491-3DEB-4502-848B-FE7769EFD216Q40483882-D15BC615-54C3-494B-A3C4-9110B2EE59DAQ40721414-D92C0BFB-B524-4102-A5E5-69804B2F6655Q44345756-E8C5D1BB-33E3-47D8-B278-39193C9BFAB1Q44430989-00432B36-E2E4-425F-B59D-C79F7E8D95EFQ45022918-8B568062-C220-40EF-9C26-24382BF0A9B0Q47896258-6C3A68E7-A255-4D21-9CE0-CA3BBABA628AQ48097060-CE4A0232-B6C8-4067-85B9-D846040CAE2AQ48155274-49ED74F5-A1BB-4D0A-AF92-2F64D3F276AEQ48176645-8A854854-A1FF-41E9-8BC7-EE9142E4101FQ48314848-83C6663D-0F78-439D-A5B2-3D11E905C32FQ48320513-90083DCF-8666-4249-8334-089B96BAF088Q48479784-83951EB5-D345-479F-9818-53E2FE7AABF2Q48518411-B3C7A215-F4A6-4802-9806-5E8AA1311976Q58450142-2B10F622-640E-406E-812E-73A3C2E44242Q60474559-433793CB-466D-4B77-8247-35E2B49BD698Q64450781-DD6E1032-2483-4892-BBC2-F6EC2A41EA02Q71589593-109BC257-AB1D-4D7D-9D15-77BACD726B0AQ72358437-9108B9C1-3A78-4A12-8F25-6A1C9FC62120Q89235723-D7F164C2-276B-4A1B-B70A-EA46B2EE9DE2Q92525019-8E3F5CFB-3925-4742-AB0C-3E867100E642
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Andrés Ozaita
@ast
Andrés Ozaita
@en
Andrés Ozaita
@es
Andrés Ozaita
@nl
type
label
Andrés Ozaita
@ast
Andrés Ozaita
@en
Andrés Ozaita
@es
Andrés Ozaita
@nl
altLabel
Andres Ozaita
@en
prefLabel
Andrés Ozaita
@ast
Andrés Ozaita
@en
Andrés Ozaita
@es
Andrés Ozaita
@nl
P214
P1053
H-3411-2015
P106
P21
P214
P2798
P31
P496
0000-0002-2239-7403
P735
P7859
viaf-305872731